This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pro-Dex, Inc. Appoints Harold A. Hurwitz As Chief Financial Officer

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced the appointment of Harold A. ("Hal") Hurwitz as Chief Financial Officer, effective October 6, 2010.  Mr. Hurwitz succeeds Jeffrey J. Ritchey who has left the Company.

"Hal comes to Pro-Dex with a broad financial background that includes Big 4 public accounting experience as a Partner with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, as well as public and private company financial management responsibility," commented Mark Murphy, Pro-Dex's Chief Executive Officer.  "We are delighted to have Hal on our team to help accomplish the goals we have established."  Commenting on Mr. Ritchey, Mr. Murphy continued, "On behalf of the entire Board of Directors, I want to thank Jeff for his dedication to Pro-Dex over the last nine years.  We greatly appreciate the contributions he has made, particularly in having served the company in multiple capacities during its development.  We wish him well in his future endeavors."

"I am privileged to be joining Pro-Dex at this exciting time," said Mr. Hurwitz. "Pro-Dex's ability to strengthen itself even through the uncertainties of the recent economic environment is impressive, and I look forward to being part of the leadership team that continues to build upon these strengths to position the company for future growth."

Through February 2010, Mr. Hurwitz was Vice President and Chief Financial Officer for Interventional Spine Inc., a medical device company focused on percutaneous systems for treatment of back pain.  Prior to that, he was a Principal Consultant with McDermott & Bull, a retained executive search firm where he specialized in serving the life science industry.   From 1997 through 2004, Mr. Hurwitz was Vice President and Chief Financial Officer for Micro Therapeutics, Inc., a developer and manufacturer of interventional neurovascular medical devices.  Mr. Hurwitz began his career with Coopers & Lybrand LLP, where he served for 22 years, leading its life science and high technology practices in Orange County.  

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,919.07 +6.78 0.04%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,746.5910 -44.5610 -0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs